"10.1371_journal.pone.0066361","plos one","2013-06-20T00:00:00Z","Tae-Hoon Chung; George Mulligan; Rafael Fonseca; Wee Joo Chng","Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore; Millenium: The Takeda Oncology, Cambridge, Massachusetts, United States of America; Mayo Clinic Comprehensive Cancer Center, Scottsdale, Arizona, United States of America; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Department of Haematology-Oncology, National University Cancer Institute of Singapore, National University Health System, Singapore, Singapore","Conceived and designed the experiments: THC GM RF WJC. Performed the experiments: THC WJC. Analyzed the data: THC. Contributed reagents/materials/analysis tools: THC. Wrote the paper: THC GM RF WJC.","GM is an employee of Millenium: The Takeda Oncology Company. RF has received consulting fees from Medtronic, Otsuka, Celgene, Genzyme, BMS, Lilly, Millenium and AMGEN. He also has sponsored research from Cylene and Onyx. WJC has received research funding from Celgene and Roche, as well as honorarium from Novartis, Merck, Celgene, Janssen, and Bristol-Myers Squibb. However, this does not alter the authorsâ€™ adherence to all the PLOS ONE policies on sharing data and materials.","2013","06","Tae-Hoon Chung","THC",4,TRUE,4,2,1,4,TRUE,TRUE,FALSE,0,NA,FALSE
